Accessibility Menu
TerrAscend logo

TerrAscend

(TSX) TSND

Current PriceCA$0.92
Market CapCA$287.89M
Since IPO (2017)-23%
5 Year-93%
1 Year+155%
1 Month+9%

TerrAscend Financials at a Glance

Market Cap

CA$287.89M

Revenue (TTM)

$261.74M

Net Income (TTM)

-$81.53M

EPS (TTM)

-CA$0.37

P/E Ratio

-2.49

Dividend

CA$0.00

Beta (Volatility)

1.33 (Average)

Price

CA$0.92

Volume

154,010

Open

CA$0.93

Previous Close

CA$0.93

Daily Range

CA$0.90 - CA$0.94

52-Week Range

CA$0.33 - CA$2.00

Estimated Earnings Date

Aug 6, 2026

TSND News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TerrAscend

Industry

Pharmaceuticals

Employees

1,038

CEO

Ziad Ghanem, PharmD

Headquarters

Mississauga, ON L5B 1M5, CA

TSND Financials

Key Financial Metrics (TTM)

Gross Margin

51%

Operating Margin

17%

Net Income Margin

-31%

Return on Equity

-22%

Return on Capital

9%

Return on Assets

-15%

Earnings Yield

-40.16%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$287.89M

Shares Outstanding

309.56M

Volume

154.01K

Avg. Volume

309.07K

Financials (TTM)

Gross Profit

$133.19M

Operating Income

$45.41M

EBITDA

$62.92M

Operating Cash Flow

$22.07M

Capital Expenditure

-$8.76M

Free Cash Flow

$13.31M

Cash & ST Invst.

$37.82M

Total Debt

$256.49M

TerrAscend Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$64.46M

-9.2%

Gross Profit

$32.51M

-11.7%

Gross Margin

50.43%

N/A

Market Cap

CA$287.89M

N/A

Market Cap/Employee

CA$303.04K

N/A

Employees

950

N/A

Net Income

-$8.91M

+34.3%

EBITDA

$15.78M

+19.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$39.50M

+30.7%

Total Debt

$254.03M

+3.3%

Accounts Receivable

$15.56M

-17.1%

Inventory

$36.26M

-22.8%

Long Term Debt

$241.72M

+3.2%

Short Term Debt

$12.30M

+6.8%

Return on Assets

-14.84%

N/A

Return on Invested Capital

9.11%

N/A

Free Cash Flow

$7.54M

+61.8%

Operating Cash Flow

$8.39M

+4.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DR.TOMedical Facilities Corporation
CA$17.95+0.79%
XLY.TOAuxly Cannabis Group Inc.
CA$0.18+0.00%
WEED.TOCanopy Growth Corporation
CA$1.34+0.75%
ACB.TOAurora Cannabis Inc.
CA$4.13+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CRVOCervoMed
$6.88+0.81%
AALAmerican Airlines Group
$16.00+0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.64-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$82.73+0.07%

Questions About TSND

What is the current price of TerrAscend?

TerrAscend is trading at CA$0.92 per share.

What is the 52-week range for TerrAscend?

Over the past 52 weeks, TerrAscend has traded between CA$0.33 and CA$2.00.

How much debt does TerrAscend have?

As of the most recent reporting period, TerrAscend reported total debt of $354.26M.

How much cash does TerrAscend have on hand?

TerrAscend reported $54.59M in cash and cash equivalents in its most recent financial results.

What is TerrAscend’s dividend yield?

TerrAscend does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.